Legacy Wealth Asset Management LLC Decreases Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Legacy Wealth Asset Management LLC decreased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 1.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 161,616 shares of the company’s stock after selling 2,798 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Takeda Pharmaceutical were worth $2,298,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Ballentine Partners LLC lifted its position in shares of Takeda Pharmaceutical by 48.9% during the 3rd quarter. Ballentine Partners LLC now owns 31,094 shares of the company’s stock valued at $442,000 after buying an additional 10,205 shares in the last quarter. McAdam LLC purchased a new position in shares of Takeda Pharmaceutical during the 3rd quarter valued at approximately $183,000. Signaturefd LLC lifted its position in shares of Takeda Pharmaceutical by 28.6% during the 3rd quarter. Signaturefd LLC now owns 45,311 shares of the company’s stock valued at $644,000 after buying an additional 10,070 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of Takeda Pharmaceutical by 14.4% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,306 shares of the company’s stock valued at $374,000 after buying an additional 3,318 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its stake in Takeda Pharmaceutical by 62.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 17,759 shares of the company’s stock valued at $253,000 after purchasing an additional 6,852 shares during the last quarter. Hedge funds and other institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Stock Down 1.7 %

NYSE TAK opened at $13.57 on Friday. The business has a fifty day moving average price of $14.59 and a 200 day moving average price of $13.77. Takeda Pharmaceutical Company Limited has a one year low of $12.57 and a one year high of $15.08. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.74 and a current ratio of 1.26. The company has a market cap of $42.95 billion, a P/E ratio of 24.67, a P/E/G ratio of 0.27 and a beta of 0.54.

Takeda Pharmaceutical (NYSE:TAK) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.37 by $0.19. Takeda Pharmaceutical had a return on equity of 10.11% and a net margin of 6.02%. The firm had revenue of $7.75 billion during the quarter. Research analysts anticipate that Takeda Pharmaceutical Company Limited will post 1.58 EPS for the current fiscal year.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.